Dupilumab在特应性皮炎以外皮肤病中的应用
Chinese Journal of Dermatovenerology of Integrated Traditional and Western Medicine(2023)
Abstract
2017年,度普利尤单抗(Dupilumab)获批成为一种治疗中重度特应性皮炎(AD)的有效药物,在适应证以外的慢性皮肤病治疗中也显示出了疗效.在病例报告和病例系列中,已报道Dupilumab在治疗慢性瘙痒症、结节性痒疹(PN)、湿疹、荨麻疹、大疱性类天疱疮(BP)方面的有效应用.临床试验正在评估Dupilumab对接触性皮炎(CD)、慢性手部湿疹(CHE)、斑秃(AA)、慢性自发性荨麻疹(CSU)和胆碱能性荨麻疹的疗效.
MoreAI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined